What to Expect Next in Health Care Policy
This memorandum titled What to Expect Next in Health Care Policy provides insight on what to expect next in health care policy following last week’s withdrawal of the American Health…
President Trump’s 2018 Budget
Here is a memo summarizing the Trump administration’s proposed budget for FY 2018. Notably, the budget lists funding for Ryan White providers as one of HHS’ “highest priorities.” The memo…
HRSA Delays 340B Ceiling Price/Manufacturer CMP Rule to May 22, 2017
The Health Resources and Services Administration (HRSA) has delayed until May 22, 2017 the effective date of the 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation,…
AIR-340B Allies Ask Congress to Change the 340B Program
The Alliance for Integrity and Reform of 340B (AIR-340B), an advocacy group funded by the pharmaceutical industry and oncologists, has told Congress how to scale back the 340B Program. The…
ACA Repeal and Replace
House Republicans released last night a draft plan for repeal and replace of the Affordable Care Act (ACA). The House Energy and Commerce Committee and Ways and Means Committee each…
GAO Reviewing 340B Contract Pharmacy Arrangements
The U.S. Government and Accountability Office (GAO) is examining 340B contract pharmacy arrangements, although we do not yet know the purpose of the GAO’s review. The GAO is the investigative…
Manufacturers Increase WAC Prices for HIV Medications
Several manufacturers of leading antiretroviral drugs increased wholesale acquisition cost (WAC) prices at the beginning of this year, despite an open letter submitted by the Fair Pricing Coalition and more…
Cuomo Proposes Medicaid Price Ceiling for High Cost Drugs
New York Governor Andrew Cuomo announced last month a proposal to control drug prices in the state that would effectively create a price ceiling on what the state Medicaid agency…
Humana/Aetna Deal Off
Aetna and Humana announced today that they will terminate their merger agreement. Last month, a federal judge blocked the proposed transaction on the grounds that the purchase would violate federal…
BREAKING NEWS – Mega-Guidance Withdrawn
HRSA withdrew its Mega-Guidance from White House review. The Office of Budget and Management announced the action on its Reginfo.gov website. White House review is normally the last step before…